162 related articles for article (PubMed ID: 25233929)
21. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
[TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinoma.
Planagumà J; Liljeström M; Alameda F; Bützow R; Virtanen I; Reventós J; Hukkanen M
Hum Pathol; 2011 Jan; 42(1):57-67. PubMed ID: 20970160
[TBL] [Abstract][Full Text] [Related]
23. Schwann cells promote EMT and the Schwann-like differentiation of salivary adenoid cystic carcinoma cells via the BDNF/TrkB axis.
Shan C; Wei J; Hou R; Wu B; Yang Z; Wang L; Lei D; Yang X
Oncol Rep; 2016 Jan; 35(1):427-35. PubMed ID: 26530352
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas.
Huszar M; Pfeifer M; Schirmer U; Kiefel H; Konecny GE; Ben-Arie A; Edler L; Münch M; Müller-Holzner E; Jerabek-Klestil S; Abdel-Azim S; Marth C; Zeimet AG; Altevogt P; Fogel M
J Pathol; 2010 Apr; 220(5):551-61. PubMed ID: 20077528
[TBL] [Abstract][Full Text] [Related]
25. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
Ziegler E; Hansen MT; Haase M; Emons G; Gründker C
Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421
[TBL] [Abstract][Full Text] [Related]
26. CUL4A regulates endometrial cancer cell proliferation, invasion and migration by interacting with CSN6.
Wang X; Chen T
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179082
[TBL] [Abstract][Full Text] [Related]
27. BMI‑1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor.
Yu J; Chen L; Bao Z; Liu Y; Liu G; Li F; Li L
Oncol Rep; 2020 May; 43(5):1630-1640. PubMed ID: 32323819
[TBL] [Abstract][Full Text] [Related]
28. Clinical prognostic significance and pro-metastatic activity of RANK/RANKL via the AKT pathway in endometrial cancer.
Wang J; Liu Y; Wang L; Sun X; Wang Y
Oncotarget; 2016 Feb; 7(5):5564-75. PubMed ID: 26734994
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of Frizzled-7 expression inhibits migration, invasion, and epithelial-mesenchymal transition of cervical cancer cell lines.
Deng B; Zhang S; Miao Y; Zhang Y; Wen F; Guo K
Med Oncol; 2015 Apr; 32(4):102. PubMed ID: 25740178
[TBL] [Abstract][Full Text] [Related]
30. BDNF mediated TrkB activation contributes to the EMT progression and the poor prognosis in human salivary adenoid cystic carcinoma.
Jia S; Wang W; Hu Z; Shan C; Wang L; Wu B; Yang Z; Yang X; Lei D
Oral Oncol; 2015 Jan; 51(1):64-70. PubMed ID: 25456007
[TBL] [Abstract][Full Text] [Related]
31. Over-expression of platelet-derived growth factor-D promotes tumor growth and invasion in endometrial cancer.
Wang Y; Qiu H; Hu W; Li S; Yu J
Int J Mol Sci; 2014 Mar; 15(3):4780-94. PubMed ID: 24646915
[TBL] [Abstract][Full Text] [Related]
32. ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer.
Devis L; Martinez-Garcia E; Moiola CP; Quiles MT; Arbos MA; Stirbat TV; Brochard-Wyart F; García Á; Alonso-Alconada L; Abal M; Diaz-Feijoo B; Thomas W; Dufour S; Mancebo G; Alameda F; Reventos J; Gil-Moreno A; Colas E
Oncotarget; 2018 Mar; 9(24):16648-16664. PubMed ID: 29682175
[TBL] [Abstract][Full Text] [Related]
33. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1.
Qiu MT; Fan Q; Zhu Z; Kwan SY; Chen L; Chen JH; Ying ZL; Zhou Y; Gu W; Wang LH; Cheng WW; Zeng J; Wan XP; Mok SC; Wong KK; Bao W
Oncotarget; 2015 Oct; 6(31):31702-20. PubMed ID: 26397136
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.
Zhu M; Li M; Wang T; Linghu E; Wu B
Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460
[TBL] [Abstract][Full Text] [Related]
35. Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma.
Montserrat N; Mozos A; Llobet D; Dolcet X; Pons C; de Herreros AG; Matias-Guiu X; Prat J
Hum Pathol; 2012 May; 43(5):632-43. PubMed ID: 21940036
[TBL] [Abstract][Full Text] [Related]
36. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
37. IL-32θ inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer.
Bak Y; Kwon T; Bak IS; Hong J; Yu DY; Yoon DY
Oncotarget; 2016 Feb; 7(6):7307-17. PubMed ID: 26824417
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition.
Lin CY; Tsai PH; Kandaswami CC; Lee PP; Huang CJ; Hwang JJ; Lee MT
Cancer Sci; 2011 Apr; 102(4):815-27. PubMed ID: 21219539
[TBL] [Abstract][Full Text] [Related]
39. ARID1A and PI3-kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion.
Wilson MR; Reske JJ; Holladay J; Wilber GE; Rhodes M; Koeman J; Adams M; Johnson B; Su RW; Joshi NR; Patterson AL; Shen H; Leach RE; Teixeira JM; Fazleabas AT; Chandler RL
Nat Commun; 2019 Aug; 10(1):3554. PubMed ID: 31391455
[TBL] [Abstract][Full Text] [Related]
40. Identification of chimeric TSNAX-DISC1 resulting from intergenic splicing in endometrial carcinoma through high-throughput RNA sequencing.
Li N; Zheng J; Li H; Deng J; Hu M; Wu H; Li W; Li F; Lan X; Lu J; Zhou Y
Carcinogenesis; 2014 Dec; 35(12):2687-97. PubMed ID: 25239642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]